AI’s Role in Reducing Healthcare Waste and Cost

By Michael Awood

October 19, 2023

Healthcare expenditure continues to rise, despite advances in medical training and technology. We’ve touched on this before, using an example from the US, where they have experienced these escalating costs. This was largely healthcare expenditure waste. Unfortunately, underperforming public services and poor health outcomes have been coupled with this. This, however, created the shift towards more efficient, cost-effective solutions. One such solution is the use of Artificial Intelligence (AI) in healthcare, and its role in reducing healthcare waste and cost.

AI has the potential to dramatically reduce inefficiencies in the healthcare system, leading to a more streamlined and cost-effective health ecosystem. This integration into healthcare is able to transform the approach to patient safety, hospital administration, drug development, and treatment decisions. AI is paving the way for rapid care management, enabling healthcare professionals to access real-time patient information at the touch of a button. This ability to quickly access and analyse patient data can significantly reduce casualties in emergency situations. The main outcome created is that of value

 

 The Economic Implications of AI in Healthcare

A start-up, backed by the University of Toronto, recently created a supercomputer algorithm to evaluate millions of potential Ebola treatments. This breakthrough creates value through cost and time reduction, and more importantly, it saves lives by improving existing treatments. With consumers (patients) increasingly using wearables, AI utilises this data for early detection of disease. This again reduces healthcare costs. In the referenced study it showed that AI significantly reduces healthcare costs compared to conventional methods.

The cost-saving due to AI used in treatment which has been found to be more effective than in diagnosis. AI not only enhances diagnostic accuracy but also minimizes inaccurate examinations, comforting patients.  In terms of time, AI-assisted tools require less time for diagnosis, resulting in cost savings. For instance, in the initial year, the time savings amount to 3.33 hours per day, and by the tenth year, the time saving reaches 15.17 hours per day. 

 

The Future of AI in Healthcare

AI must meet established quality requirements and importantly regulatory bodies must certify it. This will assist in the utilisation within healthcare, leading to full integration into existing systems. It would be important to conduct an economic analysis to compare the costs of AI-based diagnosis and treatment approaches with conventional approaches. These results show that it can significantly reduce healthcare costs compared to conventional methods.

AI possesses the potential to optimise the healthcare industry by reducing costs, improving efficiency, and enhancing patient care. However, to fully realise this potential, it is crucial to integrate AI into healthcare in a way that is economically viable and meets established quality standards.

 

Cover and in-text images taken from the article in the reference URL below

Reference url

Recent Posts

datopotamab deruxtecan approval
   

FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Treatment

💡 *What does the FDA’s latest approval mean for patients with advanced breast cancer?*
Datopotamab deruxtecan (Datroway) has just been approved for treating unresectable or metastatic HR-positive, HER2-negative breast cancer, offering new hope for patients who have already undergone multiple therapies. This breakthrough, stemming from the TROPION-Breast01 trial, showcases significant improvements in progression-free survival rates—a vital advancement in cancer care.

Curious about the implications of this treatment for both healthcare providers and patients? Dive into the full article to learn more!

#SyenzaNews #oncology #HealthcareInnovation

surrogate endpoints guidance
          

Surrogate Endpoints Guidance: New International Report Enhances HTA Practices

🔍 Are surrogate endpoints the key to shaping the future of health technology assessment?

A new report led by NICE reveals standardized guidance for using surrogate endpoints in health economic models, providing clarity and validation tools for HTA decisions. This collaborative effort across multiple global agencies aims to enhance predictions of long-term health benefits from short-term data.

Jump into the article to explore these impactful insights and learn how this guidance is set to improve health technology evaluations!

#SyenzaNews #HealthEconomics #HealthcareInnovation

cervical cancer prevention
    

Cervical Cancer Prevention Strategies: Insights from South African

🌍 Did you know South African women living with HIV face a significantly higher risk of cervical cancer?

Our latest article looks into the perspectives of women and their partners regarding innovative cervical cancer prevention strategies, including the acceptability of the intravaginal 5-fluorouracil (5FU) treatment. It highlights the critical role of education and counseling in improving screening uptake and treatment adherence.

Explore how we can enhance cervical health for vulnerable populations!

#SyenzaNews #globalhealth #oncology #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.